Ravindra Kasliwal

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

Hank F. Kung, Sangren Pan, Mei‐Ping Kung et al. · PubMed · 1989 · 164 citations

Ibzm Binding, Experimental Pharmacology, Social Sciences +16

Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide

Hank F. Kung, Ravindra Kasliwal, Sangren Pan et al. · Journal of Medicinal Chemistry · 1988 · 83 citations · Full text

Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies

Robert J. Lechleider, Edvardas Kaminskas, Xiaoping Jiang et al. · Clinical Cancer Research · 2008 · 66 citations · Full text

High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial.

D M Schrier, Salomon M. Stemmer, Tara Johnson et al. · PubMed · 1995 · 52 citations

Cell Therapy, Breast Oncology, Mx-diethylenetriaminepentaacetic Acid +19

Autoradiographic Measurement of Cerebral Lactate Transport Rate Constants in Normal and Activated Conditions

James L. Lear, Ravindra Kasliwal · Journal of Cerebral Blood Flow & Metabolism · 1991 · 35 citations